-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Discussion on a Treatment Option for Sickle Cell Disease

Sponsor: Global Blood Therapeutics/Pfizer Inc
Program: Product Theaters
Sunday, December 11, 2022: 8:00 AM-9:00 AM
Hall J - Theater 4 (Ernest N. Morial Convention Center)
Clark Brown, MD, Global Blood Therapeutics/Pfizer Inc.
No relevant conflicts of interest to declare.
For in-person participants only
See more of: Product Theaters